Form 4: Exponent CEO Catherine Corrigan Executes Stock Options

Exponent CEO Catherine Corrigan exercised stock options and sold shares in a planned transaction under Rule 10b5-1.

Summary

• CEO Catherine Corrigan exercised options for 11,211 shares of Exponent (EXPO) common stock across two dates in March and April 2026.
• A total of 7,820 shares were sold to cover exercise costs and tax obligations, resulting in a net increase in direct holdings.
• Transactions were executed pursuant to a pre-arranged Rule 10b5-1 trading plan.
• Following these transactions, the CEO maintains a direct beneficial ownership of 104,359 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event; it is a routine administrative exercise of equity compensation by an executive.

Positives

• The CEO maintains a significant equity stake of 104,359 shares, aligning interests with shareholders.
• Transactions were conducted under a pre-established Rule 10b5-1 plan, indicating systematic financial planning rather than reactive selling.

Negatives

• The sale of 7,820 shares represents a reduction in potential future upside for the executive, though this is standard for option exercise liquidity.

Risks

• Reliance on Rule 10b5-1 plans does not eliminate market risk or the potential for negative perception regarding executive selling activity.

Future Outlook

No specific forward-looking guidance regarding company operations was provided in this regulatory filing.

Industry Context

StockSavvy.ai notes that executive stock option exercises are routine corporate governance events. The use of Rule 10b5-1 plans is a standard industry practice to ensure compliance with insider trading regulations and to provide transparency to the market.

Comparison to Industry Standards

• The transaction volume is consistent with typical executive compensation and liquidity management patterns for mid-cap firms.
• The use of Rule 10b5-1 plans is considered best practice for corporate officers to avoid potential conflicts of interest.

Stakeholder Impact

• Minimal impact on shareholders as the transactions were pre-planned and executed at market prices.

Next Steps

• No further actions required by the reporting person regarding these specific transactions.

Key Dates

Keywords

Exponent, EXPO, Insider Trading, Form 4, Executive Compensation, Stock Options